A once-daily GLP-1/GIP/glucagon receptor tri-agonist (NN1706) lowers body weight in rodents, monkeys and humans by Brian Finan, Jonathan D. Douros, Ronald Goldwater, Ann Maria Kruse Hansen, Julie B. Hjerpsted, Karina Rahr Hjøllund, Martin K. Kankam, Patrick J. Knerr, Anish Konkar, Stephanie A. Mowery, Timo D. Müller, John Rømer Nielsen, Sune Boris Nygård, Diego Perez-Tilve, Kirsten Raun, Bin Yang, Matthias H. Tschöp, Richard D. DiMarchi

Subjects: Get full text

Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspective by Jorge Rico-Fontalvo, Maricely Reina, María José Soler, Mario Unigarro-Palacios, Juan Pablo Castañeda-González, Javier Jiménez Quintero, María Raad-Sarabia, Thyago Proença de Moraes, Rodrigo Daza-Arnedo

Subjects: Get full text

PANCREATIC AND EXTRA-PANCREATIC EFFECTS OF INCRETINS AND PERSPECTIVES FOR STUDYING ENTEROINSULIN HORMONAL SYSTEM DURING GESTATIONAL DISORDER OF CARBOHYDRATE METABOLISM by T. V. Saprina, Ye. S. Timokhina, N. N. Musina, T. S. Prokhorenko, L. A. Tashireva, O. K. Goncharevich

Subjects: “…incretins…”
Get full text

Exendin-4(1-32)K-Capric Acid, a Glucagon-Like Peptide-1 Receptor Agonist, Suppresses Food Intake via Arcuate Pro-Opiomelanocortin Neurons by Sujin Yoo, Eun-Seon Yoo, Jae Il Kim, Jong-Woo Sohn

Subjects: “…incretins…”
Get full text

Retatrutide—A Game Changer in Obesity Pharmacotherapy by Vasiliki Katsi, Georgios Koutsopoulos, Christos Fragoulis, Kyriakos Dimitriadis, Konstantinos Tsioufis

Subjects: Get full text

Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications by Elena Valer'evna Biryukova

Subjects: Get full text

New prospects in the treatment of diabetes mellitus by Minara Shamkhalovna Shamkhalova, Natalya Petrovna Trubitsyna, Marina Vladimirovna Shestakova

Subjects: Get full text

Incretin-responsive human pancreatic adipose tissue organoids: A functional model for fatty pancreas research by E. Lorza-Gil, O.D. Strauss, E. Ziegler, K. Kansy, M.-T. Katschke, G. Rahimi, D. Neuscheler, L. Sandforth, A. Sandforth, G. Sancar, B. Kaufmann, D. Hartmann, S. Singer, A.L. Mihaljevic, R. Jumpertz-von Schwartzenberg, J. Sbierski-Kind, T.D. Müller, A.L. Birkenfeld, F. Gerst

Subjects: Get full text

Ileal transposition in surgical treatment for type 2 diabetes mellitus by Oleg Viktorovich Kornyushin, Mikhail Michailovich Galagudza, Alexander Evgen'evich Neymark, Alina Yur'evna Grineva, Elena Nikolaevna Babenko

Subjects: Get full text

The protective role of GLP-1 in neuro-ophthalmology by Sohum Sheth, Aashay Patel, Marco Foreman, Mohammed Mumtaz, Akshay Reddy, Ramy Sharaf, Siddharth Sheth, Brandon Lucke-Wold

Subjects: Get full text

The Gut Microbiome’s Influence on Incretins and Impact on Blood Glucose Control by Ajay S. Dulai, Mildred Min, Raja K. Sivamani

Subjects: Get full text

Features of carbohydrate metabolism and incretin secretion in patients with Cushing disease and acromegaly by Lubov V. Matchekhina, Ekaterina A. Shestakova, Zhanna E. Belaya, Lyudmila I. Astafieva, Larisa V. Nikankina, Marina V. Shestakova

Subjects: Get full text

Effect of GIP and GLP-1 infusion on bone resorption in glucose intolerant, pancreatic insufficient cystic fibrosis by Wang Shin Lei, XianYan Chen, Lingyu Zhao, Tanicia Daley, Bradley Phillips, Michael R. Rickels, Andrea Kelly, Joseph M. Kindler

Subjects: “…Incretins…”
Get full text

THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS: RISKS AND PROSPECTS by L. Yu. Morgunov

Subjects: Get full text

Increase in circulating GLP-1 following low FODMAP diet in irritable bowel syndrome patients by Umael Khan, Ingeborg Brønstad, Ingeborg Brønstad, Eline Margrete Randulff Hillestad, Eline Margrete Randulff Hillestad, Elisabeth K. Steinsvik, Elisabeth K. Steinsvik, Elisabeth K. Steinsvik, Trygve Hausken, Trygve Hausken, Trygve Hausken, Birgitte Berentsen, Birgitte Berentsen, Gülen Arslan Lied, Gülen Arslan Lied, Gülen Arslan Lied

Subjects: Get full text

Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes by Nina A. Petunina, Milena Е. Telnova

Subjects: Get full text

Pancreatic β‐cell Function is Higher in Morning Versus Intermediate Chronotypes With Obesity by Steven K. Malin, Mary‐Margaret E. Remchak, Emily M. Heiston, Chiara Fabris, Ankit M. Shah

Subjects: Get full text

Physiology and pharmacology of glucagon-like peptide-1 receptor by D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, V. I. Petrov, A. V. Strygin, K. N. Koryanova, Yu. V. Gorbunova, Yu. A. Kolosov, O. V. Ivanova, E. V. Pavlova, M. A. Dzhavakhyan, A. V. Zaborovsky, V. B. Saparova, I. E. Makarenko, R. I. Drai, A. N. Chumachenko

Subjects: Get full text

The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus by Marina Vladimirovna Shestakova

Subjects: “…incretins…”
Get full text

Incretins today: multiple effects and therapeutic potential by Oksana V. Tsygankova, Varvara V. Veretyuk, Alexander S. Ametov

Subjects: “…incretins…”
Get full text